Genomics study launches to optimise childhood cancer care in Ireland
It is hoped that the MAGIC-I study will support earlier diagnosis and personalised treatment
Read More
Author: Emily Kimber
Patrick Daly
Terumo BCT has appointed Patrick Daly as Chief Business Officer
Read More
UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read More
Noah Goodman
Kymera Therapeutics has appointed Noah Goodman as Chief Business Officer
Read More
Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine
Read More- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
